BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vidovic A, Arsic-Arsenijevic V, Tomin D, Djunic I, Jakovic R, Loncar Z, Barac A. Proven invasive pulmonary mucormycosis successfully treated with amphotericin B and surgery in patient with acute myeloblastic leukemia: a case report. J Med Case Rep. 2013;7:263. [PMID: 24299522 DOI: 10.1186/1752-1947-7-263] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Virginio ED, Kubitschek-Barreira PH, Batista MV, Schirmer MR, Abdelhay E, Shikanai-Yasuda MA, Lopes-Bezerra LM. Immunoproteome of Aspergillus fumigatus using sera of patients with invasive aspergillosis. Int J Mol Sci 2014;15:14505-30. [PMID: 25141105 DOI: 10.3390/ijms150814505] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
2 Gerlach MM, Lippmann N, Kobelt L, Petzold-Quinque S, Ritter L, Kiess W, Siekmeyer M. Possible pulmonary Rhizopus oryzae infection in a previously healthy child after a near-drowning incident. Infection 2016;44:361-4. [PMID: 26365402 DOI: 10.1007/s15010-015-0839-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
3 Voltan AR, Quindós G, Alarcón KP, Fusco-Almeida AM, Mendes-Giannini MJ, Chorilli M. Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy? Int J Nanomedicine 2016;11:3715-30. [PMID: 27540288 DOI: 10.2147/IJN.S93105] [Cited by in Crossref: 51] [Cited by in F6Publishing: 22] [Article Influence: 10.2] [Reference Citation Analysis]
4 Arsenijević VA, Denning DW. Estimated Burden of Serious Fungal Diseases in Serbia. J Fungi (Basel) 2018;4:E76. [PMID: 29941824 DOI: 10.3390/jof4030076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Feng Y, Guo W, Wang Y, Shi W, Liu C, Li D, Qiu Y, Shi D. Rhinocerebral mucormycosis caused by Rhizopus oryzae in a patient with acute myeloid leukemia: A case report. WJD 2020;8:1-9. [DOI: 10.5314/wjd.v8.i1.1] [Reference Citation Analysis]
6 Miura K, Kobayashi N, Ito I, Uematsu N, Ueki T, Nakano Y, Kobayashi H. Pulmonary mucormycosis developed during acute myelogenous leukemia and successfully treated by surgical resection before blood stem cell transplantation. AME Case Rep 2019;3:48. [PMID: 32030366 DOI: 10.21037/acr.2019.11.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Chermetz M, Gobbo M, Rupel K, Ottaviani G, Tirelli G, Bussani R, Luzzati R, Di Lenarda R, Biasotto M. Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature. Mycopathologia 2016;181:723-33. [PMID: 27350324 DOI: 10.1007/s11046-016-0021-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
8 Feng J, Sun X. Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome. Infection 2018;46:503-12. [DOI: 10.1007/s15010-018-1149-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]